Insider Trading Activity For Citius Pharmaceuticals Inc (NASDAQ:CTXR)
Myron Z Holubiak , CEO of Citius Pharmaceuticals Inc (NASDAQ:CTXR) reportedly Bought 558,597 shares of the company’s stock at an average price of 0.9 for a total transaction amount of $502,737.30 SEC Form
Insider Trading History For Citius Pharmaceuticals Inc (NASDAQ:CTXR)
Analyst Ratings History For Citius Pharmaceuticals Inc (NASDAQ:CTXR)
- On 2/7/2019 HC Wainwright Reiterated Rating Buy with a price target of $3.00
- On 9/6/2019 Dawson James Initiated Coverage of rating Buy with a price target of $7.00
Recent Trading Activity for Citius Pharmaceuticals Inc (NASDAQ:CTXR)
Shares of Citius Pharmaceuticals Inc closed the previous trading session at 0.74 up +0.020 2.74% with 98652 shares trading hands.